Back to Tom Steyer
Tom Steyer → BBIO via FARALLON CAPITAL MANAGEMENT, L.L.C.
Tom Steyer BBIO Position History
BridgeBio Pharma, Inc. • Healthcare
Quarters held
10
Latest value
$800.1M
Q2 2026
Peak value
$800.1M
First seen
Q4 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $800.1M | 10.74M | — | — |
| Q1 2026 | $695.5M | 9.37M | — | — |
| Q4 2025 | $688.3M | 9.00M | — | — |
| Q3 2025 | $425.5M | 8.19M | — | — |
| Q3 2025 | $425.5M | 8.19M | — | — |
| Q2 2025 | $341.1M | 7.90M | — | — |
| Q1 2025 | $198.1M | 5.73M | — | — |
| Q4 2024 | $115.1M | 4.20M | — | — |
| Q3 2024 | $44.5M | 1.75M | — | — |
| Q4 2023 | $242K | 6.0K | — | — |